
Sign up to save your podcasts
Or


UC Davis psychology professor Charan Ranganath discusses how he and his colleagues are working to find biomarkers to help identify people with preclinical Alzheimer’s disease. Earlier detection — before the brain is significantly damaged — would allow for more successful interventions and better outcomes.
By UC DavisUC Davis psychology professor Charan Ranganath discusses how he and his colleagues are working to find biomarkers to help identify people with preclinical Alzheimer’s disease. Earlier detection — before the brain is significantly damaged — would allow for more successful interventions and better outcomes.